Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in

  News Archive

Genalyte Announces $44 Million Financing
Wednesday, August 19, 2015
San Diego based diagnostic company aims to place single drop of blood testing platform in physician offices.

N-of-One Selected to Provide Interpretation Services for Spectrum'sTumor Panel
Wednesday, August 19, 2015
N-of-One, Inc. has announced that it has signed an agreement with Spectrum Health to provide clinical interpretation for all cases sequenced on Spectrum Health’s 50-gene hot-spot solid tumor panel.

Dentists Tapped for New Role: Drug Screenings
Tuesday, August 18, 2015
A visit to the dentist has the potential to be more than a checkup of our teeth as patients are increasingly screened for medical conditions like heart disease and diabetes.

CPTAC Establishes Formal Relationships with Two Academic Institutions in Taiwan
Tuesday, August 18, 2015
The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) has entered into memorandum of understandings (MOUs) with Chang Gung University and Academia Sinica, in Taipei, Taiwan.

Multigene Testing Proves Useful for Breast and Ovarian Cancer
Tuesday, August 18, 2015
A study by researchers at three academic medical centers has shown that screening women with a suspected risk of hereditary breast or ovarian cancer for risk-associated genes other than BRCA1 and 2 provides information that can change clinical recommendations for patients and their family members.

Windber Institutes, Soon-Shiong Molecular Institute Partner to Create Cancer Research Center
Monday, August 17, 2015
The agreements include the creation of a precision cancer research and treatment institute at WMC and WRI.

Engineering Therapeutic Proteins into Antibodies
Monday, August 17, 2015
Scripps research and rockefeller scientists work on obesity therapy as proof-of-principle.

BCBS Plan Covers Interpace MDx Tests for Thyroid Cancer
Monday, August 17, 2015
Interpace Diagnostics have announced that both the ThyGenX™ Thyroid Oncogene Panel and ThyraMIR™ Thyroid miRNA Classifier, its molecular diagnostic tests for indeterminate thyroid nodules, are now covered by one of the largest independent Blue Cross Blue Shield plans that insures 3.3 million lives.

First Tenants at The BioHub Birmingham
Friday, August 14, 2015
The BioHub Birmingham has welcomed its first tenants into its £7million new facility.

<< 10 11 12 13 14 15 16 >>
Showing Results 121 - 130 of 1907
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos